DURHAM, N.C. (WNCN) — A Durham man with stage four lung cancer credits a Duke clinical trial for giving him his life back.

Scientists at the Cancer Research Manchester Institute have created a new model of Lung Squamous Cell Carcinoma (LUSC), a common type of lung cancer, to study the development, activity, and ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

are shown attacking and breaking apart a cancer cell. Credit: Yu Zhao The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer.

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases. The move isn’t shocking ...

Listen to Story India's first Car-T cell therapy showed 73% response rate This therapy is used to for the treatment of blood cancers It modifies the body's immune cells to kill cancer cells After over ...

"It's much like doing a medical CT scan where you can see inside of the cell non-destructively, so you don't have to cut the cell open," says Carolyn Larabell, a cell biologist at UC San Francisco.

What causes lung cancer, and what are the risk factors? Lung cancer is caused by cells that keep dividing or mutating. While cell division is a normal process, all cells have a built-in off switch ...

NicheCompass leverages the power of generative AI to create a visual database combining spatial genomic data on cell types ... changes across breast and lung cancer patients.

The study combined the HER2-targeting dendritic cell vaccines with standard chemotherapy, demonstrating both safety and positive response rates. Moffitt Cancer Center researchers have discovered a ...

Smoking isn’t the only lifestyle choice that might be damaging your lungs. Scientists have uncovered a surprising new villain in the fight against lung cancer: the combination of sugar and fat in your ...

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...